This sounds very big (Colchicine).
Post on X · CirculationCirculation on X#Editorial Affordable and widely available Colchicine shows promise in reducing atherothrombotic risk in ASCVD by stabilizing coronary plaques and reducing inflammation. @bweber04 @AbbateAntonio https://t.co/Z2yXOHh0Pyx.comPlaque reduction: statins, PCSK9 inhibitors and ezetimibe have the strongest evidence
Ranks interventions for regressing or stabilizing atherosclerotic plaque. Statins, PCSK9 inhibitors and ezetimibe have the strongest trial evidence, with high-dose EPA and pioglitazone fairly good; colchicine, aged garlic, Centella, pine bark, nattokinase and plant-based diets are promising but need rigorous imaging RCTs, and evidence for exercise, L-arginine and vitamin K2 is limited.



